Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

The Agniveer Common Entrance Exam 2025 was held between June 30 and July 10, with the General Duty segment conducted from ...

Study Initiation Marks Key Milestone in Advancing Precision Psychiatry Treatment for Major Depressive Disorder ...

Up. Right-wing influencer Mike Cernovich—who received a "Phase 1" binder from Trump's Attorney General Pam Bondi ea ...

Baron Health Care Fund declined for the quarter but outperformed its benchmark, the Russell 3000 Health Care Index. Read more ...

During the year ended April 30, 2025, net cash provided by financing activities was $10.4 millionStockholder equity of $4.0 million at April 30, 2025, including $3.9 million of cashIn May 2025, ...

AI founder Elon Musk provided an update on the company's second Memphis campus, including plans to start bringing the site ...

One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.

Here’s the latest on recovery efforts for the roadway that’s been closed for nearly a year. More openings are expected soon.

Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...

APSCHE will release AP EAMCET 2025 first phase seat allotment result soon. Candidates are advised to visit — ...

Nevada's new unemployment insurance portal is up and running successfully, state officials said Tuesday, after a multi-year, ...